| |||||||||
Stock Symbol: LLY
Lilly Corp Center
Indianapolis, IN 46285
317-276-2000 (phone)
317-276-3492 (fax)
Website: Eli Lilly
Index Membership: S&P 500; S&P 1500 Super Comp
Industry: Major Drugs
News releases - read news releases for Eli Lilly and Co
Eli Lilly and Co Description:
Eli Lilly and Company was incorporated in 1901 in Indiana to succeed to the drug manufacturing business founded in Indianapolis, Indiana, in 1876 by Colonel Eli Lilly. They discover, develop, manufacture, and sell products in one significant business segment — pharmaceutical products. They also have an animal health business segment. They manufacture and distribute their products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Their products are sold in approximately 140 countries.
Most of the products they sell today were discovered or developed by their own scientists, and their success depends to a great extent on their ability to continue to discover and develop innovative new pharmaceutical products. They direct their research efforts primarily toward the search for products to prevent and treat human diseases. They also conduct research to find products to treat diseases in animals and to increase the efficiency of animal food production.
They sell most of their products worldwide. They adapt their marketing methods and product emphasis in various countries to meet local needs.
In the United States, they distribute pharmaceutical products principally through independent wholesale distributors, with some sales directly to pharmacies. their marketing policy is designed to assure that products and relevant medical information are immediately available to physicians, pharmacies, hospitals, public and private payers, and appropriate health care professionals throughout the country.
Large purchasers of pharmaceuticals, such as managed-care groups, government agencies, and long-term care institutions, account for a significant portion of total pharmaceutical purchases in the United States. They have created special business groups to service managed-care organizations, government and long-term care institutions, hospital contract administrators, and certain retail pharmacies. In response to competitive pressures, they have entered into arrangements with a number of these organizations providing for discounts or rebates on one or more Lilly products.
Outside the United States, they promote their pharmaceutical products primarily through sales representatives. While the products marketed vary from country to country, neuroscience products constitute the largest single group in total sales. Distribution patterns vary from country to country. In most countries, they maintain their own sales organizations. In some countries, however, they market their products through independent distributors
Back to: companies that begin with the letter "E"